Sean P. Forestell is a notable inventor based in Menlo Park, CA. He has made significant contributions to the field of biotechnology, particularly in the development of retroviral packaging cell lines. With a total of 2 patents, his work has implications for gene therapy applications.

Latest Patents

Forestell's latest patents include a method for obtaining retroviral packaging cell lines that produce high-quality retroviral vectors. This invention provides a method for obtaining a recombinant retroviral packaging cell capable of producing retroviral vectors. The recombinant packaging cell obtained by this method is crucial for producing recombinant retroviral particles. The process involves introducing a recombinant retroviral vector into the packaging cells and propagating the resulting producer cells under conditions favorable for the production and secretion of retroviral vector supernatant. Additionally, the invention includes methods for screening retroviral vector supernatant for high transduction efficiency, which is essential for effective gene therapy applications.

Career Highlights

Sean P. Forestell has been associated with Systemix, Inc., where he has furthered his research and development efforts. His work has been instrumental in advancing the understanding and application of retroviral vectors in therapeutic settings.

Collaborations

Forestell has collaborated with notable colleagues, including Richard J. Rigg and Jingyi Chen, to enhance the impact of his research and innovations.

Conclusion

Sean P. Forestell's contributions to the field of biotechnology, particularly through his patents and collaborations, highlight his role as an influential inventor. His work continues to pave the way for advancements in gene therapy and retroviral technology.